Mesoblast | MSB - Net Income

Stock Price
2.39
Daily Change
-0.08 -3.24%
Monthly
-12.77%
Yearly
-18.15%
Q1 Forecast
2.48

Mesoblast reported $-54.21M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Avita Medical AUD -9.92M 1.67M Jun/2025
Clinuvel Pharmaceuticals AUD 24.7M 13.76M Jun/2024
Cochlear AUD 91.9M 113.2M Jun/2025
CSL USD 497.5M 1.51B Jun/2025
Pacific Edge NZD -19.12M 3.68M Dec/2025
Paradigm Biopharmaceuticals AUD -6.42M 495.95K Jun/2025
PYC Therapeutics AUD -12.37M 13.2M Jun/2025
Ramsay Health Care AUD 120.3M 225.2M Jun/2025
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Starpharma Holdings AUD -2.3M 3.09M Jun/2025
Telix Pharmaceuticals AUD 10.13M 19.52M Dec/2024